Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Curr Treat Options Gastroenterol. 2022 Jun 17;20(3):250–260. doi: 10.1007/s11938-022-00389-8

Table 2:

Knowledge gaps and research priorities for the study of sarcopenia in inflammatory bowel diseases (IBD)

Knowledge Gap Research Priorities
Lack of standardized and tailored measures of sarcopenia in patients with IBD Determine the cross-sectional imaging assessment of muscle quantity, as well as IBD-specific cutoff values
Include prospective measures of muscle strength as part of operational definition of sarcopenia
Describing trajectories of sarcopenia in patients with IBD Characterize how modifiable risk factors for sarcopenia in patients with IBD
Determine time course of reversibility of sarcopenia in patients with IBD
Determining associations with sarcopenia in patients with IBD Characterize how sarcopenia is an independent predictor of:
  • Adverse medical therapeutic outcomes

  • Need for surgical management

  • Post-operative outcomes

  • Disease recurrence